PsyMed Ventures
Signal active
Investment Firm
Overview
Psymed Ventures is an investment syndicate that invests in early-stage psychedelics companies. The firm was founded in 2020 by Matias Serebrinsky and Dina Burkitbayeva and is headquartered in San Francisco, California, United States.
Highlights
Founded
2020
Industry
Financial Services
Employees
1-10
Investment
18
Lead Investment
0
Exits
2
Stages
Seed, Early Stage Venture
Investor Type
Syndicate, Venture Capital
Location
United States, North America
Contact Information
Social
Profile Resume
PsyMed Ventures, established in 2020 and headquartered in United States, North America., specializes in Seed, Early Stage Venture investments across Biotechnology, Therapeutics, Financial Services, Venture Capital, Finance, Health Care, Health Diagnostics, Information Technology, Software, Internet. The organization boasts a portfolio of 17 investments, with an average round size of $20.1M and 2 successful exits. Their recent investments include Freedom Biosciences, Manta Ray Ventures, Remepy, 97212 Ventures, Firstime Venture Capital. The highest investment round they participated in was $39.0B. Among their most notable exits are Freedom Biosciences and Manta Ray Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
PsyMed Ventures has made 18 investments. Their most recent investment was on May 01, 2024, when Remepy raised $10.0M.
PsyMed Ventures has made 5 diversity investments. Their most recent diversity investment was on Jan 24, 2023, when Journey Clinical raised $8.5M.
investments
18
Diversity investments
5
Lead investments
0
Number of exits
2
Investments
18
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jan 24, 2023 | Journey Clinical | Health Care | 8.5M |
| Feb 28, 2023 | Motif Neurotech | Health Care | 100.0K |
| Jan 24, 2024 | Motif Neurotech | Health Care | 18.8M |
| May 01, 2024 | Remepy | Biotechnology | 10.0M |
Exits
2
Funding Timeline
Funding rounds
18
Investors
1
Funds
1
Funding Rounds
18
PsyMed Ventures has raised 18 rounds. Their latest funding was raised on May 01, 2024 from a Seed Round - Remepy round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jan 24, 2023 | Series A - Journey Clinical | - | 8.5M | - |
| Feb 28, 2023 | Seed Round - Motif Neurotech | - | 100.0K | - |
| Jan 24, 2024 | Series A - Motif Neurotech | - | 18.8M | - |
| May 01, 2024 | Seed Round - Remepy | - | 10.0M | - |
Investors
1
PsyMed Ventures is funded by 1 investor(s). DWS Holdings Inc. Kantor is the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
DWS Holdings Inc. | No | Venture Round - PsyMed Ventures | 0 |
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.